慢性中心性浆液性脉络膜视网膜病变:维替泊芬光动力治疗后的早期与晚期形态和功能变化
研究前瞻性纳入慢性中心性浆液性脉络膜视网膜病变患者接受标准维替泊芬光动力治疗,在治疗后7天内多个时间点及1、3、12个月复查。识别出三种早期反应模式;尽管治疗后早期可能出现视力与视网膜敏感度骤降,但12个月时最终平均最佳矫正视力提高14.4个字母、视网膜敏感度回升,95%病例神经上皮脱离完全消退。
要点
- 光动力治疗后1周内神经上皮脱离最常见为快速下降(12/19例),其中50%完全消退。
- 治疗后1周视网膜敏感度在16/19例下降,平均恶化2.56 dB(P=0.0002),但12个月时平均回升2.69 dB(P=0.0039)。
- 12个月时最终平均最佳矫正视力提高14.4个字母(P=0.001),神经上皮脱离完全消退18/19例(95%)。
核心结论
- 慢性中心性浆液性脉络膜视网膜病变接受标准光动力治疗后可识别出三种早期反应模式;治疗后早期最佳矫正视力与视网膜敏感度的骤然下降并不妨碍视觉功能的最终改善。
研究设计与样本
- 前瞻性研究,纳入慢性中心性浆液性脉络膜视网膜病变患者并接受标准光动力治疗。
- 基线行完整眼科检查,包括最佳矫正视力、荧光素眼底血管造影、吲哚菁绿血管造影、谱域光学相干断层扫描和微视野检查。
- 治疗后7天内多个时间点及1、3、12个月重复谱域光学相干断层扫描、微视野和最佳矫正视力检查。
主要发现
- 1周检查识别出三种早期反应模式:神经上皮脱离快速下降12/19例(其中50%完全消退)、神经上皮脱离高度增加3/19例(16%)、神经上皮脱离大幅波动4/19例(21%)。
- 神经上皮脱离快速下降组中5/12例最佳矫正视力显著下降,其余病例稳定或改善。
- 治疗后1周视网膜敏感度在16/19例下降,平均恶化2.56 dB(P=0.0002)。
- 12个月时最终平均最佳矫正视力提高14.4个字母(P=0.001),视网膜敏感度平均回升2.69 dB(P=0.0039)。
- 12个月时神经上皮脱离完全消退18/19例(95%),中心凹脉络膜厚度平行显著降低(P<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe early and late morphological and functional changes in subjects receiving photodynamic therapy (PDT) for chronic central serous chorioretinopathy. METHODS: Patients with chronic central serous chorioretinopathy were prospectively enrolled and received standard PDT. At the baseline examination, each subject underwent complete ophthalmological examination, including best-corrected visual acuity (BCVA) assessment, fluorescein angiography and indocyanine green angiography, spectral domain optical coherence tomography, and microperimetry. Spectral domain optical coherence tomography, microperimetry, and BCVA assessment were repeated in multiple sections over 7 days after PDT and at 1-, 3-, and 12-month intervals. Main outcome measures were: identification of early changes (1-week examination) in BCVA, retinal sensitivity, and spectral domain optical coherence tomography parameters and their influence on outcomes at the 1-year follow-up. RESULTS: Three main patterns of early response to PDT were identified during the 1-week examination. The neurosensory retinal detachment most frequently decreased rapidly (12/19 pts), with complete resolution in 50% of cases. An increase in neurosensory retinal detachment height was registered in 16% (3/19) of cases, whereas in 21% (4/19), a large fluctuation in neurosensory retinal detachment was encountered. Best-corrected visual acuity declined significantly in 5/12 patients in the first group and was stable or improved in the remaining cases. Overall, retinal sensitivity diminished in 16/19 subjects, with a mean worsening of 2.56 dB (P = 0.0002). At the 12-month examination, final mean BCVA improved by 14.4 letters (P = 0.001) and a similar progressive recovery in the retinal sensitivity was observed (+2.69 dB, P = 0.0039). The neurosensory retinal detachment completely resolved in 18/19 (95%) cases, with a parallel significant reduction in central foveal choroidal thickness (P < 0.0001). CONCLUSION: Three patterns of early response to standard PDT can be identified. Although an early and abrupt reduction in BCVA and retinal sensitivity after treatment is possible, this does not compromise a final improvement in visual functions.
引用
- Iacono P, Tedeschi M, Boccassini B, et al. CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Early and Late Morphological and Functional Changes After Verteporfin Photodynamic Therapy. Retina. 2019. PMID: 29346241. doi:10.1097/IAE.0000000000002040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。